
United Therapeutics Corp (NASDAQ:UTHR) reported second-quarter financial results before the market open on Wednesday. Here’s a rundown of the report.
- Q2 Revenue: $798.6 million, versus estimates of $805.48 million

United Therapeutics Corp (NASDAQ:UTHR) reported second-quarter financial results before the market open on Wednesday. Here’s a rundown of the report.